No difference was found at month 12 in percentage of VZV- reactive CD4+ (total, CM and EM) nor in VZV- reactive CD8+ memory cells between patients with and without a kidney transplant and between both patient groups and donors (Table S4). This evidence concerns the gene CD4 and urogenital neoplasm.